223P Efficacy and safety of weekly nab-paclitaxel (nab-P) plus gemcitabine (Gem) in Chinese patients (Pts) with metastatic adenocarcinoma of the pancreas (MPC): A phase II study
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2015-12, Vol.26, p.ix42-ix42 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | ix42 |
|---|---|
| container_issue | |
| container_start_page | ix42 |
| container_title | Annals of oncology |
| container_volume | 26 |
| creator | Yu, X. Shen, L. Hao, J. Wang, L. Pan, H. Han, G. Xu, J. Zhang, Y. Yang, S. Ying, J. Li, M. Begic, D. Lu, B. Xu, R. |
| description | |
| doi_str_mv | 10.1093/annonc/mdv523.84 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdv523_84</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419463278</els_id><sourcerecordid>S0923753419463278</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1344-e876c2dcf3518bbb73d56ffeb795c89d3da2e2ff1d6611deabefb015198aefb83</originalsourceid><addsrcrecordid>eNp1kEFv2zAMhYViBZq1u-_IY3JwK1m2Y_dWBF0XoMNy2M4GTVGLNls2LLWdf9b-4RRk153IR-J7JJ4QH5W8VbLRd-j96OluMK9lrm_r4kKsVFk1WS0L9U6sZJPrbFvq4kq8D-GnlLJq8mYl_uS5PsCjtY6QFkBvIKDluMBo4Y35V7-Axy6bkHoX8Tf3sD7pwwam_iXADx4ozTvnGdZPPGzAedgdkwwME0bHPgZYH2LYwJuLRxg4YohpQYCG_Ug4k_PjgKeD8XiCPM2MCfpy2G3u4QGmIyaz_R5CfDHLjbi02Af-8K9ei--fHr_tPmfPX5_2u4fnjJQuiozrbUW5IatLVXddt9WmrKzlbtuUVDdGG8w5t1aZqlLKMHZsO6lK1dSYulpfC3n2pXkMYWbbTrMbcF5aJdtT5O058vYceVsXCbk_I5z-enU8t4FSAMTGzUyxNaP7P_wXMCKNsg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>223P Efficacy and safety of weekly nab-paclitaxel (nab-P) plus gemcitabine (Gem) in Chinese patients (Pts) with metastatic adenocarcinoma of the pancreas (MPC): A phase II study</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Yu, X. ; Shen, L. ; Hao, J. ; Wang, L. ; Pan, H. ; Han, G. ; Xu, J. ; Zhang, Y. ; Yang, S. ; Ying, J. ; Li, M. ; Begic, D. ; Lu, B. ; Xu, R.</creator><creatorcontrib>Yu, X. ; Shen, L. ; Hao, J. ; Wang, L. ; Pan, H. ; Han, G. ; Xu, J. ; Zhang, Y. ; Yang, S. ; Ying, J. ; Li, M. ; Begic, D. ; Lu, B. ; Xu, R.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdv523.84</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><ispartof>Annals of oncology, 2015-12, Vol.26, p.ix42-ix42</ispartof><rights>2015 European Society for Medical Oncology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Yu, X.</creatorcontrib><creatorcontrib>Shen, L.</creatorcontrib><creatorcontrib>Hao, J.</creatorcontrib><creatorcontrib>Wang, L.</creatorcontrib><creatorcontrib>Pan, H.</creatorcontrib><creatorcontrib>Han, G.</creatorcontrib><creatorcontrib>Xu, J.</creatorcontrib><creatorcontrib>Zhang, Y.</creatorcontrib><creatorcontrib>Yang, S.</creatorcontrib><creatorcontrib>Ying, J.</creatorcontrib><creatorcontrib>Li, M.</creatorcontrib><creatorcontrib>Begic, D.</creatorcontrib><creatorcontrib>Lu, B.</creatorcontrib><creatorcontrib>Xu, R.</creatorcontrib><title>223P Efficacy and safety of weekly nab-paclitaxel (nab-P) plus gemcitabine (Gem) in Chinese patients (Pts) with metastatic adenocarcinoma of the pancreas (MPC): A phase II study</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp1kEFv2zAMhYViBZq1u-_IY3JwK1m2Y_dWBF0XoMNy2M4GTVGLNls2LLWdf9b-4RRk153IR-J7JJ4QH5W8VbLRd-j96OluMK9lrm_r4kKsVFk1WS0L9U6sZJPrbFvq4kq8D-GnlLJq8mYl_uS5PsCjtY6QFkBvIKDluMBo4Y35V7-Axy6bkHoX8Tf3sD7pwwam_iXADx4ozTvnGdZPPGzAedgdkwwME0bHPgZYH2LYwJuLRxg4YohpQYCG_Ug4k_PjgKeD8XiCPM2MCfpy2G3u4QGmIyaz_R5CfDHLjbi02Af-8K9ei--fHr_tPmfPX5_2u4fnjJQuiozrbUW5IatLVXddt9WmrKzlbtuUVDdGG8w5t1aZqlLKMHZsO6lK1dSYulpfC3n2pXkMYWbbTrMbcF5aJdtT5O058vYceVsXCbk_I5z-enU8t4FSAMTGzUyxNaP7P_wXMCKNsg</recordid><startdate>20151201</startdate><enddate>20151201</enddate><creator>Yu, X.</creator><creator>Shen, L.</creator><creator>Hao, J.</creator><creator>Wang, L.</creator><creator>Pan, H.</creator><creator>Han, G.</creator><creator>Xu, J.</creator><creator>Zhang, Y.</creator><creator>Yang, S.</creator><creator>Ying, J.</creator><creator>Li, M.</creator><creator>Begic, D.</creator><creator>Lu, B.</creator><creator>Xu, R.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20151201</creationdate><title>223P Efficacy and safety of weekly nab-paclitaxel (nab-P) plus gemcitabine (Gem) in Chinese patients (Pts) with metastatic adenocarcinoma of the pancreas (MPC): A phase II study</title><author>Yu, X. ; Shen, L. ; Hao, J. ; Wang, L. ; Pan, H. ; Han, G. ; Xu, J. ; Zhang, Y. ; Yang, S. ; Ying, J. ; Li, M. ; Begic, D. ; Lu, B. ; Xu, R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1344-e876c2dcf3518bbb73d56ffeb795c89d3da2e2ff1d6611deabefb015198aefb83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yu, X.</creatorcontrib><creatorcontrib>Shen, L.</creatorcontrib><creatorcontrib>Hao, J.</creatorcontrib><creatorcontrib>Wang, L.</creatorcontrib><creatorcontrib>Pan, H.</creatorcontrib><creatorcontrib>Han, G.</creatorcontrib><creatorcontrib>Xu, J.</creatorcontrib><creatorcontrib>Zhang, Y.</creatorcontrib><creatorcontrib>Yang, S.</creatorcontrib><creatorcontrib>Ying, J.</creatorcontrib><creatorcontrib>Li, M.</creatorcontrib><creatorcontrib>Begic, D.</creatorcontrib><creatorcontrib>Lu, B.</creatorcontrib><creatorcontrib>Xu, R.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yu, X.</au><au>Shen, L.</au><au>Hao, J.</au><au>Wang, L.</au><au>Pan, H.</au><au>Han, G.</au><au>Xu, J.</au><au>Zhang, Y.</au><au>Yang, S.</au><au>Ying, J.</au><au>Li, M.</au><au>Begic, D.</au><au>Lu, B.</au><au>Xu, R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>223P Efficacy and safety of weekly nab-paclitaxel (nab-P) plus gemcitabine (Gem) in Chinese patients (Pts) with metastatic adenocarcinoma of the pancreas (MPC): A phase II study</atitle><jtitle>Annals of oncology</jtitle><date>2015-12-01</date><risdate>2015</risdate><volume>26</volume><spage>ix42</spage><epage>ix42</epage><pages>ix42-ix42</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><pub>Elsevier Ltd</pub><doi>10.1093/annonc/mdv523.84</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2015-12, Vol.26, p.ix42-ix42 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdv523_84 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| title | 223P Efficacy and safety of weekly nab-paclitaxel (nab-P) plus gemcitabine (Gem) in Chinese patients (Pts) with metastatic adenocarcinoma of the pancreas (MPC): A phase II study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T06%3A21%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=223P%20Efficacy%20and%20safety%20of%20weekly%20nab-paclitaxel%20(nab-P)%20plus%20gemcitabine%20(Gem)%20in%20Chinese%20patients%20(Pts)%20with%20metastatic%20adenocarcinoma%20of%20the%20pancreas%20(MPC):%20A%20phase%20II%20study&rft.jtitle=Annals%20of%20oncology&rft.au=Yu,%20X.&rft.date=2015-12-01&rft.volume=26&rft.spage=ix42&rft.epage=ix42&rft.pages=ix42-ix42&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdv523.84&rft_dat=%3Celsevier_cross%3ES0923753419463278%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0923753419463278&rfr_iscdi=true |